Professor Gordon Dougan Receives the 2020 Albert B. Sabin Gold Medal; Sabin Vaccine Institute’s New Rising Star Award Presented to Dr. Katherine E. Gallagher

Sabin today announced that it has awarded its annual Albert B. Sabin Gold Medal to Gordon Dougan, FRS, professor in the Department of Medicine and the Cambridge Institute for Therapeutic Immunology and Infectious Disease at the University of Cambridge. Sabin also presented the inaugural Rising Star Award to Katherine E. Gallagher, MSc, PhD, assistant professor of epidemiology at the London School of Hygiene and Tropical Medicine.

Statement Regarding Industry Funding

Approved by Board of Trustees May 2020

Sabin partners with multiple organizations in the vaccine and immunization community, including the pharmaceutical and biotechnology industry (industry), to implement its Global Immunization and Research & Development Programs. Sabin operates independently from industry and controls and restricts programs and activities that may be supported by industry as outlined below. Furthermore, this policy is reviewed annually by Sabin's Board of Trustees.

Vaccines are one of the greatest achievements in modern medical history. More lives have been saved thanks to vaccines than any other medical advance in recent years.

Sabin's President of Global Immunization Dr. Bruce Gellin Testifies at House Briefing on Approval Processes for Safe, Effective COVID-19 Vaccine

Bruce Gellin, M.D., M.P.H., president of Global Immunization at the Sabin Vaccine Institute (Sabin) and former Deputy Assistant Secretary for Health and Director of the National Vaccine Program Office at the U.S. Department of Health and Human Services (HHS), testified on July, 14, 2020, at the House Subcommittee on Economic and Consumer Policy’s briefing entitled “Guardrails to Ensure a Safe and Effective COVID-19 Vaccine.”

Sabin Vaccine Institute’s Boost Community Prepares Immunization Professionals to Lead During the COVID-19 Crisis

WASHINGTON D.C. – Amid the evolving global challenges posed by the novel coronavirus pandemic, immunization professionals must now grapple with deploying routine immunization services in a daunting and ever-shifting landscape. To strengthen immunization professionals’ ability to navigate the complex challenges of their work, Sabin launched the Boost Community (Boost), a global network dedicated to serving immunization professionals, supported by a grant from the Bill & Melinda Gates Foundation.

Amid COVID-19 Vaccine Race, Sabin Vaccine Institute and the Aspen Institute Release Report on Vaccine Hesitancy; A Call to Improve Vaccine Acceptance

WASHINGTON, D.C. -- As the COVID-19 vaccine race accelerates, experts recognize that the challenge will not end with the development of a vaccine. The extraordinary effort to make a vaccine available across the globe will only be effective if the majority of people achieve immunity through vaccination.

Below is an abridged version of the April 7, 2020, episode of the Science Rules! with Bill Nye podcast, Coronavirus Edition, featuring Dr.

Sabin Vaccine Institute Names David Salisbury, Jeffrey P. Libson to Board of Trustees, Philip K. Russell Retires to Advisory Role

WASHINGTON, D.C. – The Sabin Vaccine Institute (Sabin) today announced that Professor David Salisbury and Jeffrey P. Libson have been named to the Board of Trustees and Retired Major General Philip K. Russell will transition from Trustee to Special Advisor after more than 25 years of service to the organization.

Pages

Subscribe to RSS - Access & Uptake